BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17132062)

  • 21. US trade rules seek to balance health and patent protection.
    Wadman M; Cherry M
    Nature; 1999 Dec; 402(6762):567-8. PubMed ID: 10604448
    [No Abstract]   [Full Text] [Related]  

  • 22. Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries.
    Rovira J
    Yale J Health Policy Law Ethics; 2004; 4(2):401-13. PubMed ID: 15536921
    [No Abstract]   [Full Text] [Related]  

  • 23. Intellectual property. Plants and intellectual property: an international appraisal.
    Koo B; Nottenburg C; Pardey PG
    Science; 2004 Nov; 306(5700):1295-7. PubMed ID: 15550646
    [No Abstract]   [Full Text] [Related]  

  • 24. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S
    Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
    [No Abstract]   [Full Text] [Related]  

  • 25. Implications of bilateral free trade agreements on access to medicines.
    Correa CM
    Bull World Health Organ; 2006 May; 84(5):399-404. PubMed ID: 16710551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of civil society in protecting public health over commercial interests: lessons from Thailand.
    Ford N; Wilson D; Bunjumnong O; von Schoen Angerer T
    Lancet; 2004 Feb; 363(9408):560-3. PubMed ID: 14975620
    [No Abstract]   [Full Text] [Related]  

  • 27. International intellectual property strategies for therapeutic antibodies.
    Storz U
    MAbs; 2011; 3(6):596-606. PubMed ID: 22123063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction: Access to life-saving medicines and intellectual property rights.
    Schroeder D
    Camb Q Healthc Ethics; 2011 Apr; 20(2):277-8. PubMed ID: 21435302
    [No Abstract]   [Full Text] [Related]  

  • 29. International intellectual property, access to health care, and human rights: South Africa v. United States.
    Nagan WP
    Fla J Int Law; 2002; 14(2):155-91. PubMed ID: 16526137
    [No Abstract]   [Full Text] [Related]  

  • 30. Access to life-saving medicines and intellectual property rights: an ethical assessment.
    Schroeder D; Singer P
    Camb Q Healthc Ethics; 2011 Apr; 20(2):279-89. PubMed ID: 21435303
    [No Abstract]   [Full Text] [Related]  

  • 31. Health and intellectual property rights.
    Correa CM
    Bull World Health Organ; 2001; 79(5):381. PubMed ID: 11417031
    [No Abstract]   [Full Text] [Related]  

  • 32. Trips and public health: solutions for ensuring global access to essential AIDS medication in the wake of the Paragraph 6 Waiver.
    Greenbaum JL
    J Contemp Health Law Policy; 2008; 25(1):142-65. PubMed ID: 19137750
    [No Abstract]   [Full Text] [Related]  

  • 33. A fair deal for the future: flexibilities under TRIPS.
    So AD
    Bull World Health Organ; 2004 Nov; 82(11):813. PubMed ID: 15640914
    [No Abstract]   [Full Text] [Related]  

  • 34. A general approach for determining when to patent, publish, or protect information as a trade secret.
    Daizadeh I; Miller D; Glowalla A; Leamer M; Nandi R; Numark CI
    Nat Biotechnol; 2002 Oct; 20(10):1053-4. PubMed ID: 12355117
    [No Abstract]   [Full Text] [Related]  

  • 35. Biotech in post-TRIPS India.
    Ramani SV; Pradhan P; Ravi M
    Nat Biotechnol; 2005 Jan; 23(1):18-9. PubMed ID: 15637608
    [No Abstract]   [Full Text] [Related]  

  • 36. Amendments to the Canadian Patent Act to address drug access: is help on the way?
    Penner MD; Narayanan P
    Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
    [No Abstract]   [Full Text] [Related]  

  • 37. Does the pharmaceutical sector have a coresponsibility for the human right to health?
    Schroeder D
    Camb Q Healthc Ethics; 2011 Apr; 20(2):298-308. PubMed ID: 21435305
    [No Abstract]   [Full Text] [Related]  

  • 38. The MTA-rip it up and start again?
    Ku K; Henderson J
    Nat Biotechnol; 2007 Jul; 25(7):721-4. PubMed ID: 17621290
    [No Abstract]   [Full Text] [Related]  

  • 39. Brazil's AIDS controversy: antiretroviral drugs, breaking patents, and compulsory licensing.
    Marques UR; GuimarĂ£es VS; Sternberg C
    Food Drug Law J; 2005; 60(3):471-7. PubMed ID: 16304752
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluating the Usefulness of Compulsory Licensing in Developing Countries: A Comparative Study of Thai and Brazilian Experiences Regarding Access to Aids Treatments.
    Guennif S
    Dev World Bioeth; 2017 Aug; 17(2):90-99. PubMed ID: 27699996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.